Structures by: Manikandan N.
Total: 8
(<i>Z</i>)-3-(3,4-Dimethoxybenzylidene)-2,3-dihydro-1,5-benzothiazepin-4(5<i>H</i>)-one
C18H17NO3S
Acta Crystallographica Section E (2013) 69, 4 o562-o563
a=7.0249(4)Å b=10.7949(7)Å c=10.8826(7)Å
α=91.783(3)° β=97.562(2)° γ=108.512(2)°
(<i>Z</i>)-3-(2,4-Dichlorobenzyl)-1,5-benzothiazepin-4(5<i>H</i>)-one
C16H11Cl2NOS
Acta Crystallographica Section E (2013) 69, 4 o564
a=7.879(5)Å b=9.667(5)Å c=9.979(5)Å
α=89.052(5)° β=78.161(4)° γ=83.647(5)°
Methyl 6-methoxy-11-(4-methoxyphenyl)-16-methyl-14-phenyl-8,12-dioxa-14,15-diazatetracyclo[8.7.0.0^2,7^.0^13,17^]heptadeca-2(7),3,5,13(17),15-pentaene-10-carboxylate
C30H28N2O6
Acta Crystallographica Section E (2014) 70, 9 127-129
a=12.9549(5)Å b=14.5280(5)Å c=13.8522(4)Å
α=90.00° β=100.433(2)° γ=90.00°
Aqua(2,2-bipyridine-κ^2^<i>N</i>,<i>N</i>')(2-methylmalonato- κ^2^<i>O</i>^1^,<i>O</i>^3^)copper(II) dihydrate
C14H14CuN2O5,2(H2O)
Acta Crystallographica Section E (2012) 68, 7 m884-m885
a=10.7588(7)Å b=7.4761(6)Å c=20.1029(13)Å
α=90.00° β=90.917(6)° γ=90.00°
2-Formyl-6-methoxyphenyl cinnamate
C17H14O4
Acta Crystallographica Section E (2012) 68, 7 o2167
a=10.7908(7)Å b=10.4672(5)Å c=25.8714(17)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-2-[(2-Formylphenoxy)methyl]-3-(4-methylphenyl)prop-2-enenitrile
C18H15NO2
Acta Crystallographica Section E (2012) 68, 1 o28
a=7.0792(4)Å b=13.7006(7)Å c=15.3587(9)Å
α=90.00° β=96.782(2)° γ=90.00°
(<i>E</i>)-3-(2-Chlorophenyl)-2-[(2-formylphenoxy)methyl]prop-2-enenitrile
C17H12ClNO2
Acta Crystallographica Section E (2012) 68, 4 o934
a=7.5022(4)Å b=7.8301(4)Å c=13.2379(8)Å
α=75.470(3)° β=84.696(2)° γ=70.935(2)°
<i>N</i>-(2-Formylphenyl)-<i>p</i>--toluenesulfonamide
C14H13NO3S
Acta Crystallographica Section E (2012) 68, 4 o1009-o1010
a=11.5409(4)Å b=8.1345(2)Å c=14.1115(5)Å
α=90.00° β=97.294(2)° γ=90.00°